By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases will spend $9.3 million in Fiscal Year 2013 to fund research and development of new diagnostic and therapeutic countermeasures for use in biodefense efforts against dangerous pathogens and toxins.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.